StockData
DiaMedica Therapeutics Inc. logo

DiaMedica Therapeutics Inc. (DMAC) stock

DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$8.79−0.54 (-5.79%)

Close on Nov 13, 2026Market cap $474.01MP/E –Yield –

DiaMedica Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

DiaMedica Therapeutics's market cap was $520.92M on Nov 11, 2026, against $449.43M a year earlier. Over the last 5 years it ranged from $31.20M to $520.92M, with a median of $114.33M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$520.92M+25.7%
2025Dec 31, 2025$414.54M+78.5%
2024Dec 31, 2024$232.22M+115.4%
2023Dec 29, 2023$107.79M+158.0%
2022Dec 30, 2022$41.78M-57.6%
2021Dec 31, 2021$98.62M-48.1%
2020Dec 31, 2020$190.01M+226.3%
2019Dec 31, 2019$58.23M+214.1%
2018Dec 31, 2018$18.54M–

More DiaMedica Therapeutics figures

See a number that looks wrong?